SCP
JNJ icon

Stamos Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Stamos Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
41,659
-4,443
-10% -$1.03M 1.59% 10
2025
Q4 		$9.54M Buy
46,102
+202
+0.4% +$39.9K 1.53% 10
2025
Q3 		$8.51M Sell
45,900
-19,188
-29% -$3.29M 1.61% 14
2025
Q2 		$9.94M Buy
65,088
+24,083
+59% +$3.7M 1.78% 10
2025
Q1 		$6.8M Sell
41,005
-14,475
-26% -$2.26M 1.78% 7
2024
Q4 		$8.02M Buy
55,480
+10,580
+24% +$1.64M 1.88% 10
2024
Q3 		$7.28M Sell
44,900
-6,400
-12% -$1.02M 1.71% 11
2024
Q2 		$7.5M Buy
51,300
+2,380
+5% +$354K 1.59% 9
2024
Q1 		$7.74M Sell
48,920
-640
-1% -$102K 1.76% 11
2023
Q4 		$7.77M Sell
49,560
-2,700
-5% -$414K 2.11% 11
2023
Q3 		$8.14M Buy
52,260
+400
+0.8% +$66K 1.81% 14
2023
Q2 		$8.58M Sell
51,860
-1,260
-2% -$203K 2.01% 10
2023
Q1 		$8.23M Buy
53,120
+18,150
+52% +$2.93M 2.12% 8
2022
Q4 		$6.18M Sell
34,970
-17,010
-33% -$2.94M 1.96% 15
2022
Q3 		$8.49M Buy
51,980
+11,980
+30% +$2.03M 2.16% 12
2022
Q2 		$7.1M Hold
40,000
– – 2.15% 20
2022
Q1 		$7.09M Sell
40,000
-800
-2% -$136K 2.37% 20
2021
Q4 		$6.98M Buy
40,800
+5,150
+14% +$843K 3.24% 10
2021
Q3 		$5.76M Hold
35,650
– – 3.22% 10
2021
Q2 		$5.87M Sell
35,650
-2,050
-5% -$339K 3.1% 10
2021
Q1 		$6.2M Hold
37,700
– – 3.13% 10
2020
Q4 		$5.93M Buy
37,700
+14,200
+60% +$2.1M 2.53% 8
2020
Q3 		$3.5M Hold
23,500
– – 1.3% 21
2020
Q2 		$3.31M Sell
23,500
-14,348
-38% -$2.09M 1.89% 12
2020
Q1 		$4.96M Buy
37,848
+13,768
+57% +$1.95M 2.61% 13
2019
Q4 		$3.51M Sell
24,080
-1,420
-6% -$193K 2.83% 7
2019
Q3 		$3.3M Buy
25,500
+11,371
+80% +$1.5M 2.93% 7
2019
Q2 		$1.97M Sell
14,129
-3,411
-19% -$472K 1.97% 17
2019
Q1 		$2.43M Sell
17,540
-14,460
-45% -$1.94M 3.11% 8
2018
Q4 		$4.13M Buy
+32,000
New +$4.46M 3.11% 7

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stamos Capital Partners's JNJ Position: Q1 2026 in Review

Stamos Capital Partners reduced its Johnson & Johnson (JNJ) stake by 9.6% in Q1 2026, selling an estimated $1.03M and leaving 41,659 shares worth $10.2M. The position accounts for 1.59% of the portfolio, ranked #10.

Stamos Capital Partners first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Stamos Capital Partners held 41,659 shares of Johnson & Johnson worth $10.2M as of Q1 2026.
  • Stamos Capital Partners sold 4,443 Johnson & Johnson shares in Q1 2026, an estimated $1.03M.
  • Johnson & Johnson made up 1.59% of Stamos Capital Partners's portfolio in Q1 2026, its #10 holding.
  • Stamos Capital Partners first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.